Phase Holographic Imaging PHI AB

Equities

PHI

SE0005504636

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET Other stock markets 18:00:00 2024-01-30 EST			5-day change	1st Jan Change
6.46 ^SEK	-4.44%		-.--%	+8.39%

05-17	Phase Holographic Imaging Obtains SEK7 Million Loan Agreement	MT
03-27	Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI

BioStock: PHI's CEO reflects on the Company's momentum

November 14, 2023 at 02:18 am

Medtech company PHI has experienced a dynamic year, with multiple significant advancements resulting in a 230 per cent surge in the company's stock price so far this year. BioStock reached out to PHI's CEO, Patrik Eschricht, to delve into what latest developments have contributed to the heightened enthusiasm surrounding the company.

Read the full interview with Patrik Eschricht at biostock.se:

https://www.biostock.se/en/2023/11/phis-ceo-reflects-on-the-companys-momentum/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

https://news.cision.com/phase-holographic/r/biostock-phi-s-ceo-reflects-on-the-company-s-momentum,c3875329

Latest news about Phase Holographic Imaging PHI AB

Phase Holographic Imaging Obtains SEK7 Million Loan Agreement	05-17	MT
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	03-27	CI
Phase Holographic Imaging PHI AB Appoints Ivan Jurkovic as Ordinary Board Member	03-14	CI
Phase Holographic Imaging Presents a Comprehensive Opinion Piece Delivering the Versability and Potential the Company sees for Quantitative Phase Imaging Technology in Regenerative Medicine	03-11	CI
Phase Holographic Imaging Reports Sales Results for the Third Quarter of 2024	01-30	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	12-21	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-20	CI
European Patent Office Intends to Grant Phase Holographic Imaging AB Patent on Synthetic Antibodies	23-07-04	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2023	23-06-26	CI
Phase Holographic Imaging Phi AB Elects Goran Dubravcic Elected as A New Member of the Board	23-05-09	CI
Altium Mitkap AG acquired a 11.8% stake in Phase Holographic Imaging PHI AB from Formue Nord A/S.	23-03-07	CI
PHI expands its global network to India	23-01-24	CI
Phase Holographic Imaging Announces Management Changes	23-01-17	CI
Phase Holographic Imaging PHI AB Announces Management Changes	23-01-17	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-12-21	CI
Phase Holographic Imaging Announces Opening A New Development Office in the U.S	22-11-21	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2022	22-09-29	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2022	22-06-29	CI
PHI Enters Biomanufacturing Partnership with Wake Forest Institute for Regenerative Medicine	22-04-06	CI
Phase Holographic Imaging Installs Holomonitor Fluorescence Now At Novo Nordisk A/S	22-03-30	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	22-03-21	CI
Phase Holographic Imaging Phi AB Announces Sales Results for the Three Months and Full Year Ended January 2022	22-03-15	CI
Phase Holographic Imaging PHI AB Moves to New Premises	22-03-10	CI
Phase Holographic Imaging Introduces Non-Invasive Fluorescence Units	22-01-20	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	21-12-29	CI

Chart Phase Holographic Imaging PHI AB

Duration

Period

More charts

Company Profile

Phase Holographic Imaging PHI AB (PHI) is a Sweden-based company active in the field of medical technology. It develops and markets time-lapse cytometers for clinical applications. The products use holographic microscopy technology, with image sensors capturing light information from objects, and computer processing the information to create visual image. It is also engaged in the development of related software. Its method allows to view and measure living cell over time, without disturbing or destroying it. PHI collaborates with cancer- and stem cell researchers, among others. The Companyâs product portfolio includes HoloMonitor M3, a bench-top time-lapse cytometer, and HoloMonitor M4, allowing cell analysis in the cultivation incubator.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
PHASE HOLOGRAPHIC IMAGING PHI AB	+8.39%	16.06M
SARTORIUS AG	-27.52%	16.33B
QUIDELORTHO CORPORATION	-40.04%	2.96B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+15.16%	1.82B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-6.86%	1.55B
BIOTAGE AB	+38.67%	1.41B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-15.36%	976M
CONTEC MEDICAL SYSTEMS CO.,LTD	-26.08%	846M
REVENIO GROUP OYJ	+3.53%	811M
VAREX IMAGING CORPORATION	-24.63%	631M

Medical Diagnostic & Testing Equipment